Kyung Hee University
↗Seoul, South Korea
Kyung Hee University (KHU) is a prestigious private research university in South Korea, recognized globally for its leadership in medical and pharmaceutical sciences. It is unique for housing colleges of Western Medicine, Traditional Korean Medicine, Pharmacy, Dentistry, and Nursing on a single campus, fostering a highly collaborative environment for translational research. The university operates the Kyung Hee University Healthcare System, which includes major medical centers in Seoul and Gangdong.
KHU is a major hub for pharmaceutical innovation in Asia, particularly through its University-Industry Cooperation Group (IACF). It specializes in the commercialization of 'Biohealth' technologies, including small molecule drug discovery, RNA therapeutics, and digital health. The university is a top-tier clinical trial destination, recently certified as a 'Research-Driven Hospital' by the South Korean Ministry of Health and Welfare (2025-2028), and maintains strategic partnerships with global CROs and pharmaceutical firms to advance its extensive patent portfolio.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Academic Research & Drug Discovery
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$5M-$10M
Founded:1949
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:$6.9M
Investors:Ministry of Science and ICT (South Korea), Ministry of Health and Welfare (South Korea), Korea University Technology Holding Company (for spin-offs)
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Small molecule, RNA, Digital Health, Cell therapy, Traditional Herbal Medicine, Probiotics
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 18 | Phase 3: 15
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Kyung Hee University System
Subsidiaries:Dr. B LAB (Spin-off), Kyung Hee University Medical Center, Kyung Hee University Hospital at Gangdong
Key Partnerships:Novotech (CRO partnership for clinical trials), Samsung Electronics (Digital health R&D), 365mc (Digital therapeutics for obesity), Yuyu Pharma (Commercialization strategy), Genomictree (Cancer diagnostics), BioMarin (Clinical trial site for gene therapy)
COMPETITION
Position:Leader
Competitors:Seoul National University, Yonsei University, Sungkyunkwan University, KAIST
LEADERSHIP
Key Executives:
Hahn Kyun Tae - President
Joo Hyeong Oh - President of Kyung Hee University Healthcare System
Een-Kee Hong - Director of Industrial and Academic Cooperation Foundation
Scientific Founders:Bonglee Kim (Founder of Dr. B LAB)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kyung Hee University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.